-
公开(公告)号：EP2440925A1
公开(公告)日：2012-04-18
申请号：EP09779678.3
申请日：2009-06-08
IPC分类号： G01N33/52
CPC分类号： G01N33/52 , Y10T436/18
摘要： The invention provides methods and kits for detecting metabolites in a body fluid by contacting a sample of the body fluid with at least one reducible dye at a pH-value which is higher than the pKa-value of the reducible dye, whereby a color change resulting from reduction of the reducible dye is indicative of the presence of metabolites in the body fluid. The methods and kits are of use in the detection and monitoring of disease conditions.
-
公开(公告)号：EP2440925B1
公开(公告)日：2013-07-31
申请号：EP09779678.3
申请日：2009-06-08
IPC分类号： G01N33/52
CPC分类号： G01N33/52 , Y10T436/18
-
公开(公告)号：EP2638056B1
公开(公告)日：2016-02-24
申请号：EP11788786.9
申请日：2011-11-10
IPC分类号： C07H21/02 , A61K31/7125 , A61P31/14
CPC分类号： C07H19/207 , A61K31/7076 , A61K31/7125 , A61K45/06 , C07H21/00 , A61K2300/00
-
公开(公告)号：EP2411509A1
公开(公告)日：2012-02-01
申请号：EP10713878.6
申请日：2010-03-26
CPC分类号： G01N33/6896 , C12Q1/26 , G01N2333/90209 , G01N2800/2828
摘要： The invention relates to methods and tools for detecting and treating patients suffering from aberrant prion functioning or Aberrant Prion Disease (APD), methods for determining the presence of aberrant prion functioning-inducing agents in a sample and to methods for determining the appropriate therapy for a patient having symptoms of aberrant prion functioning based on detecting aberrant NADH oxidase activity.
-
公开(公告)号：EP2638056A1
公开(公告)日：2013-09-18
申请号：EP11788786.9
申请日：2011-11-10
IPC分类号： C07H21/02 , A61K31/7125 , A61P31/14
CPC分类号： C07H19/207 , A61K31/7076 , A61K31/7125 , A61K45/06 , C07H21/00 , A61K2300/00
摘要： The invention relates to the therapeutic uses of 2',5'-oligoadenylate derivative compounds, more particularly for the treatment of chronic fatigue syndrome (CFS) and in the treatment of infection by a gamma-retrovirus.
摘要翻译： 本发明涉及2'，5'-寡聚腺苷酸衍生物化合物的治疗用途，更具体地说，用于治疗慢性疲劳综合症（CFS）和用γ-逆转录病毒治疗感染。
-
-
-
-
搜索结果
5 条记录 (耗时 0.009 秒)
